Galeotti N., (2017). Hypericum perforatum (St John's wort) beyond
depression: A therapeutic perspective for pain conditions. Journal of
Ethno-pharmacology, 200: 136-146.
https://doi.org/10.1016/j.jep.2017.02.016
2. Barnes J., Anderson L.A. & Phillipson J.D., (2001). St John's wort
(Hypericum perforatum L.): a review of its chemistry, pharmacology
and clinical properties. Journal of Pharmacy and Pharmacology, 53(5):
583-600. https://doi.org/10.1211/0022357011775910
3. Linde K., Mulrow C.D., Berner M. & Egger M., (2005). St John's wort for
depression. Cochrane Database of Systematic Review, 2: CD000448.
https://doi.org/10.1002/14651858.cd000448.pub2
4. Nobakht S.Z., Akaberi M., Mohammadpour A.H., Tafazoli Moghadam A.
& Emami S.A., (2022). Hypericum perforatum: Traditional uses, clinical
trials, and drug interactions. Iranian Journal of Basic Medical Sciences,
25(9): 1045-1058. https://doi.org/10.22038/ijbms.2022.65112.14338
5. Gaster B. & Holroyd J., (2000). St John's wort for depression: a
systematic review. Jama Internal Medicine, 160(2): 152-156.
https://doi.org/10.1001/archinte.160.2.152
6. Ng Q.X., Venkatanarayanan N. & Ho C.Y., (2017). Clinical use of
Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Journal of Affective Disorders, 210: 211-221.
https://doi.org/10.1016/j.jad.2016.12.048
7. Di Carlo G., Borrelli F., Ernst E.& Izzo A.A., (2001), St John's wort: Prozac
from the plant kingdom. Trends Pharmacolοgical Sciences, 22(6): 292-
297. https://doi.org/10.1016/s0165-6147(00)01716-8
8. Apaydin E.A., Maher A.R., Shanman R., Booth M.S., Miles J.N., Sorbero
M.E. & Hempel S., (2004). A systematic review of St. John's wort for
major depressive disorder. Systematic Reviews, 5(1): 148.
https://doi.org/10.1186/s13643-016-0325-2
9. Mannel M., (2004). Drug interactions with St John's wort: mechanisms
and clinical implications. Drug Safety, 27(11): 773-797.
https://doi.org/10.2165/00002018-200427110-00003
10. Borrelli F. & Izzo A.A., (2009). Herb-drug interactions with St John's wort
(Hypericum perforatum): an update on clinical observations. The AAPS
Journal, 11(4): 710-27. https://doi.org/10.1208/s12248-009-9146-8
11. Soleymani S., Bahramsoltani R., Rahimi R. & Abdollahi M., (2017).
Clinical risks of St John's Wort (Hypericum perforatum) co-
administration. Expert Opinion on Drug Metabolism & Toxicology,
13(10): 1047-1062. https://doi.org/10.1080/17425255.2017.1378342
